| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |